Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate |
1998-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2002-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37bcd2e6bf1c6ef6493e4e73c4f65f1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d3c220d1d92c6085e7f6f4b72f3dfb1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45d8c593997733a009e5d62b273deb76 |
publicationDate |
2002-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6489322-B1 |
titleOfInvention |
Amidine derivatives as inhibitors of nitric oxide synthase |
abstract |
There are provided novel compounds of formula (I)wherein R1 represents a 2-thienyl or 3-thienyl ring and R2 represents hydrogen or C 1 to 4 alkyl and optical isomers and racemates thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are selective inhibitors of the neuronal isoform of nitric oxide synthase. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010183712-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8163751-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008144483-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8263587-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007082897-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011152247-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7713963-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009166652-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008144483-A2 |
priorityDate |
1997-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |